ArticleBMC cancer2026

Clinical impact of the 21-gene recurrence score on adjuvant treatment selection in elderly patients with hormone receptor-positive, HER2-negative early breast cancer.

Asuka Kochi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.